Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry

類似資料

• Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
  著者:: Pappas, Dimitrios A., 等
  出版事項: (2017)
• Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
  著者:: Harrold, Leslie R., 等
  出版事項: (2016)
• Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
  著者:: Harrold, Leslie R., 等
  出版事項: (2015)
• Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
  著者:: Pappas, Dimitrios A., 等
  出版事項: (2020)
• Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry
  著者:: Harrold, Leslie R., 等
  出版事項: (2016)